Fellowship · Syracuse, NY
Sponsored by SUNY Upstate Medical University
Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 202 citations · Anurag Singh
Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma.
The New England journal of medicine · 2022 · 422 citations · Teresa Gentile
Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 336 citations · Jade Homsi
The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2022 · 293 citations · Arun Rajan
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
The New England journal of medicine · 2022 · 277 citations · Jade Homsi
Systemic Therapy for Melanoma: ASCO Guideline Update.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 188 citations ·
Survival improvement for patients with metastatic colorectal cancer over twenty years.
NPJ precision oncology · 2023 · 166 citations · Mohammad Zeineddine
Measurable residual disease and posttransplantation gilteritinib maintenance for patients with FLT3-ITD-mutated AML.
Blood · 2025 · 52 citations · Anurag Singh